Page last updated: 2024-11-05
ochratoxin c
Description
Ochratoxin C (OTC) is a mycotoxin produced by various species of Aspergillus and Penicillium fungi. It is a structurally related compound to ochratoxin A (OTA), a known nephrotoxin and carcinogen, but with a different substitution on the isocoumarin moiety. While OTC has been reported to be less toxic than OTA, it still exhibits some biological activity. Limited research suggests potential cytotoxic effects and interference with cellular processes, but further investigation is needed to fully understand its toxicological significance. Its presence in food and feed can be a concern, particularly considering the potential for synergistic effects with other mycotoxins. OTC is studied to assess its potential risk to human and animal health and to develop strategies for its mitigation. The research aims to understand its biosynthesis, occurrence in food, and the mechanisms of its toxicity. This knowledge is crucial for implementing effective control measures and ensuring food safety.'
ochratoxin C: converted into ochratoxin A in vivo; RN given refers to (R)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ochratoxin C : A phenylalanine derivative that is the ethyl ester of ochratoxin A. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 20997 |
CHEBI ID | 141525 |
SCHEMBL ID | 455355 |
MeSH ID | M0125606 |
Synonyms (27)
Synonym |
ochratoxin c |
ethyl (2s)-2-[[(3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoate |
ethyl n-{[(3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1h-isochromen-7-yl]carbonyl}-l-phenylalaninate |
CHEBI:141525 |
4865-85-4 |
ochratoxin a ethyl ester |
ethyl (2s)-2-{[(3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1h-2-benzopyran-7-carbonyl]amino}-3-phenylpropanoate |
ethyl n-[(3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1h-2-benzopyran-7-carbonyl]-l-phenylalaninate |
unii-0dy21hw450 |
0dy21hw450 , |
alanine, n-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-, ethyl ester, l- |
hsdb 3439 |
l-phenylalanine, n-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopyran-7-yl)carbonyl)-, ethyl ester, (r)- |
l-phenylalanine, n-(((3r)-5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopyran-7-yl)carbonyl)-, ethyl ester |
ochratoxin c [mi] |
ochratoxin c [hsdb] |
SCHEMBL455355 |
ethyl 2-([(5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1h-isochromen-7-yl)carbonyl]amino)-3-phenylpropanoate # |
BPZZWRPHVVDAPT-PXAZEXFGSA-N |
l-phenylalanine, n-[(5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopyran-7-yl)carbonyl]-, ethyl ester, (r)- |
ethyl ((r)-5-chloro-8-hydroxy-3-methyl-1-oxoisochromane-7-carbonyl)-l-phenylalaninate |
Q15633527 |
DTXSID00964097 |
CS-0093077 |
HY-125699 |
l-phenylalanine, n-[[(3r)-5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopyran-7-yl]carbonyl]-, ethyl ester |
AKOS040753349 |
Research Excerpts
Toxicity
Roles (3)
Role | Description |
Aspergillus metabolite | Any fungal metabolite produced during a metabolic reaction in the mould, Aspergillus. |
Penicillium metabolite | Any fungal metabolite produced during a metabolic reaction in Penicillium. |
mycotoxin | Poisonous substance produced by fungi. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (3)
Class | Description |
alpha-amino acid ester | The amino acid ester derivative obtained the formal condensation of an alpha-amino acid with an alcohol. |
phenylalanine derivative | An amino acid derivative resulting from reaction of alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of phenylalanine by a heteroatom. The definition normally excludes peptides containing phenylalanine residues. |
isochromanes | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.47
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 17.47 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.59 (4.65) | Search Engine Demand Index | 10.37 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |